American pharmaceutical companies involved in the production of vaccines against coronavirus infection fear possible leaks to Russia and China. In this regard, their lobbyists are increasing pressure on representatives of the White House. Writes about this The Financial Times, citing sources.
According to the publication, the concern of representatives of Pfizer and Moderna is caused by the position of the administration of US President Joe Biden on the issue of a possible temporary waiver of patents for drugs from coronavirus.
They believe that the Russian Federation and the PRC will be able to use for their own purposes the technologies of matrix ribonucleic acid (mRNA), on the basis of which vaccines of American companies have been created.
Recall that the initiative to temporarily waive patents for coronavirus drugs belongs to India and South Africa due to the severity of the COVID-19 pandemic. At the moment, this initiative is supported by 60 countries.